Claus Svarer
Chief Engineer, PhD at the Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet
Data updated
Research Footprint
Claus Svarer appears in 5 tracked papers (2011–2025), most studied alongside Psilocybin, MDMA and LSD, across Neuroimaging & Brain Measures, Depressive Disorders and Anxiety Disorders.
Most-cited paper: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (491 citations).
Frequent co-authors: Gitte Knudsen, Patrick Fisher and Dea Stenbæk.
Background & Research
Claus Svarer completed an M.S. in electrical engineering at the Technical University of Denmark in 1984 and later earned a PhD in neural networks for signal processing in 1994. Since 1994 he has worked at the Neurobiology Research Unit at Rigshospitalet, focusing on signal processing, mathematical modeling, PET/fMRI analysis, and brain data modeling. His publication record includes major neuroimaging studies on serotonin transporters and 5-HT2A receptors relevant to psychedelic research.
Key Impact
He is a key PET/neuroimaging methodologist and coauthor on influential human psychedelic imaging studies linking psilocybin and LSD effects to serotonin receptor biology.
Collaboration Network
13 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Claus Svarer is associated with.
The Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet
hospitalThe Neurobiology Research Unit (NRU) at Copenhagen University Hospital – Rigshospitalet is a leading neuroimaging center led by Prof. Gitte Knudsen. Specializing in PET and MRI studies of the serotonin system, NRU has conducted landmark research on how psilocybin and other psychedelics modulate brain function and serotonin receptor binding, establishing some of the field’s key mechanistic insights.
View stakeholder →University of Copenhagen
academicThe Neurobiology Research Unit (NRU) at Copenhagen University Hospital has been carrying out clinical and preclinical research with psychedelics since 2017. The team at the NRU utilizes various neuroimaging techniques to better understand how psychedelics exert their effects on the brain. They have published numerous peer-reviewed articles on psychedelics and facilitated numerous medium-dose psilocybin sessions. The NRU is led by Professor Gitte Moos Knudsen.
View stakeholder →Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →